This is the authors' abstract. We don't add key points for this paper.
Uropathogenic E. coli (UPEC) is the predominant uropathogen in community-acquired urinary tract infections (CA-UTIs) globally. However, data from India on relationship between antimicrobial resistance, virulence factors, and clonal markers in UPEC remain scarce. We studied 80 ESBL-positive UPEC isolates causing CA-UTI across four Indian regions. Antimicrobial susceptibility done using VITEK-2. PCR assays detected ESBL genes ( bla CTX-M-15 , bla TEM ), carbapenemase genes ( bla NDM , bla OXA-48-like ), virulence genes ( fimH, pap, sfa, hlyA, aer ) and serogroup O25b. Phenotypic virulence assays assessed hemolysin, haemagglutination, biofilm and gelatinase production. All isolates susceptible to fosfomycin, with high susceptibility to nitrofurantoin (87.5%) and ertapenem (85%). Predominant resistance gene was bla CTX-M-15 (97.5%), followed by bla TEM (55%), bla NDM (16.3%) and bla OXA-48-like (5%). Biofilm formation (41.3%) most prevalent virulence trait, followed by haemagglutination (35%). Frequently detected virulence genes were pap (61.3%), fimH (55%), and aer (48.8%). The O25b serogroup found in 41.3% of isolates had lower ertapenem resistance than non-O25b strains. This study shows ESBL-producing UPEC isolates from community settings in India frequently harbour multiple beta-lactamase resistance genes and virulence factors, underscoring their adaptability and clinical threat in CA-UTIs. These findings emphasize the critical need for continued molecular surveillance, strengthened infection control, and robust antibiotic stewardship programs to mitigate the spread of multidrug-resistant, virulent UPEC strains.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kocher et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: